Zachary Rome - 26 Apr 2023 Form 4/A - Amendment Insider Report for PaxMedica, Inc.

Role: Chief Operating Officer, Director
Signature: /s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 26 Apr 2023
Net transactions value: -$15,430
Form type: 4/A - Amendment
Filing time: 01 May 2023, 19:52:38 UTC
Date Of Original Report: 28 Apr 2023
Previous filing: 14 Apr 2023
Next filing: 28 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PXMD	Common Stock	Tax liability	$15,430	-9,584	-2.5%	$1.61	378,868	26 Apr 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.
F2	The original Form 4 filed on April 28, 2023 (the "Original Form 4"), erroneously reported 6,272 shares of common stock withheld in Column 4 of the Original Form 4, as well as 382,180 shares of common stock beneficially owned following the transaction as reported in Column 5 of the Original Form 4. This amendment is being filed to disclose the correct number of shares withheld, as reported in Column 4 of the Original Form 4, as well as the number of securities beneficially owned following the transaction as reported in Column 5 of the Original Form 4. No other substantive changes have been made to the original Form 4.

Content

Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

The original Form 4 filed on April 28, 2023 (the "Original Form 4"), erroneously reported 6,272 shares of common stock withheld in Column 4 of the Original Form 4, as well as 382,180 shares of common stock beneficially owned following the transaction as reported in Column 5 of the Original Form 4. This amendment is being filed to disclose the correct number of shares withheld, as reported in Column 4 of the Original Form 4, as well as the number of securities beneficially owned following the transaction as reported in Column 5 of the Original Form 4. No other substantive changes have been made to the original Form 4.